Redaelli B
Nephrology and Dialysis Department, AO San Gerardo, Monza, Italy.
J Nephrol. 2001 Nov-Dec;14 Suppl 4:S7-11.
Hydroelectrolytic equilibrium alteration in dialysis patients before dialytic treatment consists in extracellular volume expansion and hyperkalemia. Extracellular volume expansion is due to salt and water retention. Because of the self-regulation phenomenon of cell volume, it is made prevalently at the expense of extracellular volume. Hyperkalemia derives not only from alimentary K+ retention but, above all, from the K+ intracellular transfer into extracellular volume for tamponage of acid load, owing to the same selfregulation of cell volume and to the reduction of Na+/K+ pump activity with a subsequent change in Ki/Ke ratio. Dialysis must reduce expanded extracellular volume without inducing osmolar changes. To do this, salt and water removal must occur by ultrafiltration. Moreover, it is necessary to define Na+ concentration in dialysate or in reinfusion solution able to undo, by diffusion, the plasmatic Na+ increase due to Donnan effect. K+ dialytic removal presents the problem of defining the K+ quantity to be removed: K+ fecal excretion is increased in the uremic patient and there is no correlation between the quantity of K+ removed and successive increase of kalemia. K+ removal occurs by diffusion according to the concentration gradient between plasma and dialysate through dialytic membrane. The reduction of kalemia determines, in its turn, diffusion fluxes according to the concentration gradient of intracellular K+ towards extracellular volume. Because the electrical membrane potential at rest (REMP) is due to K+ fluxes for passive transmembrane diffusion, the increase of these fluxes causes REMP increase. Cardiac activity expresses this change with the appearance of intradialytic arrhythmia. The use of a dialysate with K+ concentration that decreases during dialysis in line with K+ rate (variable K+) reduces the arrhythmias induced by dialysis. The quantity of K+ removed with this procedure is the same as that obtained by using a dialysate with K K+ constant concentration of 3 mEq/l, but the percentage removed from intracellular volume is lower with improvement of Ki/Ke ratio. The influence of intradialytic REMP increase linked to K+ removal also concerns the correction of metabolic acidosis: the acquired bicarbonate during dialysis increases on reducing removal K+ gradient. The Ki/Ke ratio is also dependent on Na+/K+ pump activity which, exchanging intracellular Na+ with extracellular K+, determines intracellular K+ retention and therefore its concentration gradient between intra and extracellular volume. In the uremic patient the retention of nitrogenous catabolites causes the slowing- down in ATP production in Krebs' cycle because of prevalent use of this low -efficiency energetic substrate; ATP supply to Na+/K+ pump, which is ATP-asi- dependent, is reduced and consequently so is pump activity. Thanks to nitrogenous catabolite removal, dialysis recovers the use of other major efficiency energetic substrates, such as carbohydrates and lipids, in Krebs' cycle with an increase of ATP production rate and pump activity. This hypothesis could explain the REMP reduction in end-stage uremia and its correction with dialysis.
透析患者透析治疗前水电解质平衡改变表现为细胞外液量增加和高钾血症。细胞外液量增加是由于盐和水潴留。由于细胞体积的自我调节现象,这种增加主要是以细胞外液量为代价的。高钾血症不仅源于饮食中钾的潴留,更主要的是由于细胞体积的自我调节以及钠钾泵活性降低导致细胞内钾转移到细胞外液以缓冲酸负荷,进而使细胞内/细胞外钾离子比例发生变化。透析必须减少扩张的细胞外液量而不引起渗透压改变。为此,必须通过超滤去除盐和水。此外,有必要确定透析液或回输溶液中的钠浓度,以便通过扩散消除因唐南效应导致的血浆钠增加。透析去除钾存在确定要去除钾量的问题:尿毒症患者粪便中钾排泄增加,且去除的钾量与随后血钾升高之间无相关性。钾通过透析膜根据血浆和透析液之间的浓度梯度经扩散去除。血钾降低反过来又根据细胞内钾向细胞外液的浓度梯度决定扩散通量。由于静息膜电位(REMP)是由钾离子经被动跨膜扩散形成的通量决定的,这些通量增加会导致REMP升高。心脏活动会以透析中出现心律失常来表现这种变化。使用透析过程中钾浓度随钾去除速率降低的透析液(可变钾透析液)可减少透析诱导的心律失常。用这种方法去除的钾量与使用钾浓度恒定为3 mEq/l的透析液相同,但从细胞内液中去除的百分比更低,细胞内/细胞外钾离子比例得到改善。与钾去除相关的透析中REMP升高的影响还涉及代谢性酸中毒的纠正:透析过程中获得的碳酸氢盐在降低钾去除梯度时会增加。细胞内/细胞外钾离子比例还取决于钠钾泵活性,钠钾泵将细胞内钠与细胞外钾交换,决定细胞内钾的潴留,从而决定细胞内和细胞外液之间的钾浓度梯度。在尿毒症患者中,含氮分解代谢产物的潴留导致三羧酸循环中ATP生成减慢,因为普遍使用这种低效率的能量底物;依赖ATP的钠钾泵的ATP供应减少,因此泵活性也降低。通过透析去除含氮分解代谢产物后,三羧酸循环中可恢复使用其他主要的高效能量底物,如碳水化合物和脂质,从而提高ATP生成速率和泵活性。这一假说可以解释终末期尿毒症患者REMP降低以及透析对其的纠正。